5-Iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects

Toxicol Lett. 2013 Mar 27;218(1):24-9. doi: 10.1016/j.toxlet.2013.01.008. Epub 2013 Jan 21.

Abstract

In 2010, an internet snapshot of EMCDDA anticipated the presence of 5-iodo-2-aminoindan (5-IAI) within the recreational drug market. In 2011, this compound, a psychoactive derivative of 2-aminoindane, was identified in recreational products sold in the United Kingdom. 5-IAI is a rigid analogue of p-iodoamphetamine producing MDMA-like effects. The aim of this paper is to summarize the clinical, pharmacological, and toxicological information about this new potential drug of abuse.

Publication types

  • Review

MeSH terms

  • 3,4-Methylenedioxyamphetamine / analogs & derivatives*
  • 3,4-Methylenedioxyamphetamine / chemistry
  • 3,4-Methylenedioxyamphetamine / toxicity
  • Forensic Toxicology*
  • Humans
  • Illicit Drugs / chemistry
  • Illicit Drugs / toxicity*
  • Indans / chemistry
  • Indans / toxicity*
  • Molecular Structure
  • Substance Abuse Detection

Substances

  • Illicit Drugs
  • Indans
  • MMDA
  • 3,4-Methylenedioxyamphetamine
  • 5-iodo-2-aminoindan